DAVID M. STACK - 31 Mar 2022 Form 4 Insider Report for Pacira BioSciences, Inc. (PCRX)

Role: CEO and Chairman, Director
Signature: /s/ Kristen Williams, Attorney-in-Fact
Issuer symbol: PCRX
Transactions as of: 31 Mar 2022
Net transactions value: +$243,225
Form type: 4
Filing time: 05 Apr 2022, 17:26:11 UTC
Previous filing: 27 Jan 2022
Next filing: 02 May 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PCRX	Common Stock	Options Exercise	$243,225	+22,500	+18%	$10.81	145,544	31 Mar 2022	Direct	F1
holding	PCRX	Common Stock						97,273	31 Mar 2022	By Three Colleens Investment, LLC	F2
holding	PCRX	Common Stock						18,596	31 Mar 2022	By Stack Schroon Mohawk FLP	F2
holding	PCRX	Common Stock						315	31 Mar 2022	LCK Investment LLC	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PCRX	Stock Option (Right to Buy)	Options Exercise	$0	-22,500	-50%	$0.000000	22,500	31 Mar 2022	Common Stock	22,500	$10.81	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
F2	Mr. Stack and his wife are the owners of each of Three Colleens Investment, LLC and LCK Investment LLC. Mr. Stack is the general partner of Stack Schroon Mohawk FLP.
F3	The option vested and became exercisable as to 25% of the option shares on June 5, 2013 and as to the remaining shares in successive equal monthly installments for the subsequent 36 months.